On July 6, 2021 AIM ImmunoTech Inc. (NYSE American: AIM) reported that it will host an investor update webcast at 11:00 a.m. Eastern Time on Wednesday, July 14, 2021, to discuss recent accomplishments and upcoming milestones (Press release, AIM ImmunoTech, JUL 6, 2021, View Source [SID1234584642]). Investors and other interested parties are invited to submit questions to management prior to the call’s start via email to [email protected].

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast may be accessed at View Source or on the Company’s website at View Source For those unable to participate at that time, a replay of the webcast will be available until Thursday, July 14, 2022 on the Company’s website.